Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Contact
News Ticker
  • [ October 23, 2021 ] Research Associate II – Analytical – FUJIFILM – Santa Ana, CA Los Angeles Biotech Jobs
  • [ October 23, 2021 ] QC Microbiology Associate II – B. Braun Medical Inc. – Irvine, CA Los Angeles Biotech Jobs
  • [ October 23, 2021 ] Biotech Sales Representative, Los Angeles South – Insmed Incorporated – Los Angeles, CA Los Angeles Biotech Jobs
  • [ October 23, 2021 ] Formulation Chemist – Developlus, Inc. – Corona, CA Los Angeles Biotech Jobs
  • [ October 23, 2021 ] Sr. Manager , Process Engineering – Process Monitoring – Kite Pharma – El Segundo, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsAmgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

March 30, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers
Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers aalidrus Tue, 03/30/2021 - 17:07

Click to view original post

Previous

Going head-to-head with Merck on I/O, Genentech vets raise fresh round and enter clinic

Next

ChromaDex and the Citrin Foundation Announce Global Research Collaboration Exploring Citrin Deficiency

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC